Filing Details

Accession Number:
0001140361-12-023480
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-08 09:34:30
Reporting Period:
2012-05-04
Filing Date:
2012-05-08
Accepted Time:
2012-05-08 09:34:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1023869 Merilee Raines One Idexx Drive
Westbrook ME 04092
Corporate Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-04 5,836 $17.14 176,857 No 4 M Direct
Common Stock Acquisiton 2012-05-04 2,608 $38.34 179,465 No 4 M Direct
Common Stock Disposition 2012-05-04 8,144 $87.03 171,321 No 4 S Direct
Common Stock Disposition 2012-05-04 300 $87.97 171,021 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-05-04 5,836 $0.00 5,836 $17.14
Common Stock Incentive Stock Option (right to buy) Disposition 2012-05-04 2,608 $0.00 2,608 $38.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-06 No 4 M Direct
0 2013-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,430 Indirect by Charitable Remainder Unitrust
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $86.6600 to $87.5600, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
  2. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $87.7300 to $88.1950, inclusive.
  3. Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/06/2008) of the grant.
  4. Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2011) of the grant.